- Molecular Mechanism Linking BRCA1 Dysfunction to High Grade Serous Epithelial Ovarian Cancers with Peritoneal Permeability and Ascites
- A Review of the Effects of Intensive Poultry Production on the Environment and Human Health
- Wake-up Strokes Are Similar to Known-Onset Morning Strokes in Severity and Outcome
- Comparison of Physicochemical and Binding Properties of Novicel™ Microcrystalline Cellulose and Avicel® PH 101 in Direct Compression of Ascorbic Acid Tablets
- Acculturation and Subclinical Atherosclerosis among U.S. South Asians: Findings from the MASALA study
- Bioequivalence Studies of Two Formulations of Rivaroxaban 10 Mg Coated Tablets under Fasting Conditions and 20 Mg Coated Tablets Under Fed and Fast Conditions And its Pharmacokinetic Comparison In Healthy Subjects
- Leukocytoclastic Vasculitis after Ceftriaxone Exposure: A Case Report and Literature Revie
- Predictors of Obstructive Sleep Apnea Risk among Blacks with Metabolic Syndrome
- Radiographic Outcomes of FDBA Block Graft for Maxillary Ridge Augmentation: A Case Report
- Prevalence and Factors Associated with Depression Among Rohingya Refugees in Bangladesh
Prion diseases, a group of disorders caused by abnormally shaped proteins called prions, occur in sporadic (Jakob-Creutzfeldt disease), genetic (genetic Jakob-Creutzfeldt disease, Gerstmann-Stra¨ussler-Scheinker syndrome.
The concept of orphan drugs for treatment of orphan genetic diseases is perceived enthusiastically at present, and this is leading to research investment on the part of governments, disease-specific foundations, and industry.
Whole-exome sequencing (WES) is increasingly used as a diagnostic tool in medicine, but prior reports focus on predominantly pediatric cohorts with neurologic or developmental disorders.
Genetically modified stem and progenitor cells have emerged as a promising regenerative platform in the treatment of genetic and degenerative disorders, highlighted by their successful therapeutic use in inherent immunodeficiencies.
Elevated concentrations of albumin in the urine, albuminuria, are a hallmark of diabetic kidney disease and associate with increased risk for end-stage renal disease and cardiovascular events.
Journal of Genetic Mutation Disorders
Journal of Genetic Mutation Disorders (JGMD) is an international open access, peer-reviewed journal for the publication of advancements and for dissemination of scientific knowledge on Genetic mutation disorders by covering all aspects like Gene therapy, hereditary genetic disorders, Medical Genetics, Clinical Genetics etc., making it to be visible for various researchers.
Online Submission SystemJournal of Genetic Mutation Disorders is using online manuscript submission, review and tracking systems for quality and quick review processing. Review processing is performed by the editorial board members of Journal of Genetic Mutation Disorders or outside experts; at least two independent reviewer's approval followed by editor approval is required for acceptance of any citable manuscript.